Oxcarbazepine
- Product NDC
- 0615-8292
- 11-digit product format
- 006158292
- Labeler code
- 0615
- Product ID
- 0615-8292_dbdc7bbb-bc4d-46f9-829f-0c5444abb915
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxcarbazepine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Application
- ANDA077794
- Marketing category
- ANDA
- Marketing start
- 2007-10-09
- Marketing end
- 2024-03-31
- Substance
- OXCARBAZEPINE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8292-39 | 00615829239 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8292-39) | 2019-06-06 | 0000-00-00 | No | No | Current |